Max and Millie Tomerlin Voelcker Fund grants UT Health San Antonio $1.25 million to support research from early career investigators
July 2, 2025
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been awarded $1.25 million by the Max and Minnie Tomerlin Voelcker Fund to support research projects being conducted by the institution’s early career inves …
Owens Medical Research Foundation awards UT Health San Antonio investigators $1.5 million to advance Alzheimer’s and cancer research
July 2, 2025
The William and Ella Owens Medical Research Foundation recently awarded $1.5 million to The University of Texas Health Science Center at San Antonio (UT Health San Antonio) for research projects that address pancreatic cancer, Alzheimer’s diseas …
New urine-based tumor DNA test may help personalize bladder cancer treatment
June 27, 2025
In a multi-institutional study published in Science Direct, researchers revealed that testing urine-based tumor DNA (utDNA) can help predict which bladder cancer patients are at higher risk for recurrence after treatment.
Key DNA complex connected to PARP inhibitor cancer-drug resistance discovered
June 9, 2025
Scientists at The University of Texas Health Science Center at San Antonio have made one of the most important discoveries to date in the study and treatment of BRCA1-deficient cancers and drug resistance.
CPRIT awards UT Health San Antonio $3.4 million to increase HPV vaccination rates in Bexar County, develop transformative technologies targeting drug-resistant cancers
June 2, 2025
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) received $3,395,970 in new academic research and prevention awards as part of the latest $98 million funding round announced on May 21 by the Cancer Prevention …
UT Health San Antonio-led discovery means IV medication could be taken orally for range of cancer, Alzheimer’s treatments
April 22, 2025
Major breakthrough could redefine drug discovery, broaden options A research team led by scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) made a major breakthrough with the potential to turn IV drugs in …
Magnesium channel key to immune cell shift offers new hope for oral cancer prevention, treatment
April 21, 2025
The ability of macrophages, a type of white blood cell, to transition into one of two forms, is critical for immune system functionality. These cells can morph into fighter cells (M1) that cause inflammation and attack invading pathogens, or nurse cell …
UT Health San Antonio scientists pioneer drug-discovery breakthrough for large and polar drugs
April 18, 2025
iStock Discovery of chemical endocytosis could redefine precision medicine A team of scientists, notably Zhengyu Wang, PhD, assistant professor in the department of pharmacology and the Barshop Institute, led by Hong-yu Li, PhD, professor of medicinal …
Breast cancer research with global impact
April 2, 2025
BRCA1 and BRCA2 are genes that help protect the body by fixing damaged DNA and keeping cells healthy. When these genes have changes, or mutations, they don’t work the way they should. This can raise the risk of certain cancers, like breast, ovarian, prostate and pancreatic cancer. These inherited mutations affect about 1 in every 200 to 300 people — over a million in the U.S. alone.
UT Health San Antonio-led research discovers a way to slow or block recurrence of glioblastoma
March 26, 2025
Researchers at The University of Texas Health Science Center at San Antonio have discovered a way to delay or even block recurrence of the deadliest brain cancer after radiation, bringing new hope for survival.